Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Sales (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Return on Sales data on record, last reported at 315.41% in Q2 2021.

  • For Q2 2021, Return on Sales fell 30140.0% year-over-year to 315.41%; the TTM value through Jun 2021 reached 315.41%, down 31444.0%, while the annual FY2025 figure was 105.07%, N/A changed from the prior year.
  • Return on Sales reached 315.41% in Q2 2021 per COGT's latest filing, down from 105.52% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.15% in Q4 2019 and bottomed at 315.41% in Q2 2021.
  • Average Return on Sales over 4 years is 47.44%, with a median of 5.24% recorded in 2018.
  • Peak YoY movement for Return on Sales: skyrocketed 296bps in 2020, then tumbled -30140bps in 2021.
  • A 4-year view of Return on Sales shows it stood at 2.26% in 2018, then surged by 107bps to 0.15% in 2019, then crashed by -7026bps to 10.42% in 2020, then tumbled by -2926bps to 315.41% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 315.41% in Q2 2021, 105.52% in Q1 2021, and 10.42% in Q4 2020.